Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)
Authors:
- 9 March 2018
- journal article
- research article
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 72 (04) , 253-308
Abstract
Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr 2007 ablöst. Die Fülle an neuen Erkenntnissen zu Risikofaktoren, Diagnostik, Schweregradeinschätzung, Prävention und medikamentösen sowie nicht medikamentösen Therapiemaßnahmen machten eine umfassende Überarbeitung erforderlich. Die neue Leitlinie baut auf das GOLD-Dokument unter Berücksichtigung von Besonderheiten in Deutschland und Österreich auf. This document is a revision of the guideline for diagnosis and treatment of COPD that replaces the version from 2007. A multitude of recent reports regarding risk factors, diagnosis, assessment, prevention and pharmacological as well as non-pharmacological treatment options made a major revision mandatory. The new guideline is based on the GOLD document taking into account specifics in Germany and Austria. * Verabschiedet von den Vorständen der beteiligten Fachgesellschaften am 24. 01. 2018.Keywords
This publication has 100 references indexed in Scilit:
- Comparison of two systemic steroid regimens for the treatment of COPD exacerbationsPulmonary Pharmacology & Therapeutics, 2014
- Antibiotics for exacerbations of chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2012
- Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trialThe Lancet, 2011
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report—2010The Journal of Heart and Lung Transplantation, 2010
- Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO indexThe Lancet, 2009
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsThe Lancet, 2009
- From COPD to chronic systemic inflammatory syndrome?The Lancet, 2007
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Does patient education modify behaviour in the management of COPD?Patient Education and Counseling, 2004
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999